R. Verma

Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations

M. Parravano, F. Holz, R. Dolz-Marco, 2021, Eye.

Brolucizumab: A Newly Developed Anti-VEGF Molecule for the Treatment of Neovascular Age-Related Macular Degeneration

R. Tadayoni, F. Holz, A. Clemens, 2020, Ophthalmologica.